Accounts

What Johnson & Johnson's Account Shift Means for MDC Partners, WPP and the Industry

Headwinds for dedicated units in 2020

Headshot of Mark Penn and Mark Read on a red background with johnson and johnson logo
Mark Penn (l.) and Mark ReadMDC, WPP, Johnson & Johnson
By Erik Oster

October 25, 2019

Earlier this week, Johnson & Johnson sent its U.S. consumer health business, which comprises Listerine, Tylenol and Zyrtec brands, from WPP’s Wunderman to MDC Partners’ Doner.

Erik Oster

Erik Oster is Adweek's senior writer covering Agencies.

Recommended articles
Microlearning
View All


Maximize the Value of First-Party Data for Today and Tomorrow


The Power of Advertising on the Second Screen


The Keys to Building Your Customer Identity Framework


Mastering the Art and Science of Subscriber Care

You Might Like


Who Are Connected Consumers and How Can You Engage and Delight Them?

By Andrew Cole


Your 5 Biggest Questions About the Future of CPG Marketing Answered

By MiQ


What the Pandemic Pet Boom Means for Marketers

By Hoang Nguyen, Business Data Journalist, YouGov


When Marketing Goes Haywire

By Smartsheet